NEW YORK (GenomeWeb) – Shares of firms operating in the molecular diagnostics and omics spaces reversed losses suffered in September as the GenomeWeb Daily News Index rose nearly 8 percent month over month in October.

Several firms in the MDx/omics arena saw sharp jumps in their share prices last month, led by Foundation Medicine, whose stock value increased more than 36 percent month over month, while Pacific Biosciences' share price was up almost 34 percent, and Genomic Health saw its share price rise 28 percent.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.